NIAID: Many factors for bump in tickborne disease cases

Tuesday, June 4, 2024 Many factors for bump in tickborne disease cases The deer tick, Ixodes scapularis, feeds for multiple days. The first day the tick produces a cement-like compound to keep its mouthparts embedded in the skin of its host. Next the tick takes in small amounts of blood and slowly begins to expand its body size. The final rapid engorgement stage sees the tick sometimes expanding 100 times its body weight. Credit: Ryan Kissinger/NIAID   Cases of human disease caused by tick bites have increased over the last decade, but climate change and greater numbers of the arachnid parasites hanging on grass and brush aren't the only reasons. A new commentary in JAMA Internal Medicine from NIAID and Tufts University identifies several factors contributing to the rise in cases: better tests to diagnose illnesses; an increasing population of older, active people who are apt to be in areas prone to tick bites and to seek medical care when ill; urbanization and increasing numbers of "backyard wildlife" that support tick populations, such as deer.  The authors suggest that increased case trends will continue – but note that vaccines for Lyme disease are in advanced clinical trials. As for climate change: It is a factor, but more study is needed to evaluate impacts. Their advice for remaining healthy in tick environs: use repellents, look for ticks on clothing and the body, and promptly remove any that are attached to the skin. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

American Heart Association: New telehealth stroke certification available to health care professionals

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

June 04, 2024
New telehealth stroke certification available to health care professionals

https://newsroom.heart.org/news/new-telehealth-stroke-certification-available-to-health-care-professionals

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

American Heart Association: Nueva certificación en telesalud para ataque o derrame cerebral disponible para profesionales de la salud

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

June 04, 2024
Nueva certificación en telesalud para ataque o derrame cerebral disponible para profesionales de la salud

https://newsroom.heart.org/news/nueva-certificacion-en-telesalud-para-ataque-o-derrame-cerebral-disponible-para-profesionales-de-la-salud

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

American Heart Association: Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

June 04, 2024
Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050

https://newsroom.heart.org/news/population-shifts-risk-factors-may-triple-u-s-cardiovascular-disease-costs-by-2050

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

The presence of autoantibodies was associated with severe infections that typically only occur when a person's immune system is suppressed.

Monday, June 3, 2024 Unpacking the Interplay between Autoimmunity and Immunodeficiency Autoantibodies binding and neutralizing the inflammatory cytokine interleukin 23 (IL-23). Neutralization of IL-23 is associated with severe, persistent opportunistic infections in patients where they are present. Credit: NIAID The presence of antibodies that target one of the body's own proteins was associated with severe infections that typically only occur when a person's immune system is suppressed, based on a multi-cohort study of blood samples from more than 1,000 people. This study suggests autoimmune processes could be involved in the development of immunodeficiency in adulthood. The findings of this NIAID study were published in The New England Journal of Medicine. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

American Heart Association: Impact Update: CPR willingness grows in the U.S., need to act remains

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

June 03, 2024
Impact Update: CPR willingness grows in the U.S., need to act remains

https://newsroom.heart.org/news/impact-update-cpr-willingness-grows-in-the-u-s-need-to-act-remains

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

NIAID has funded discovery and development of the delta inulin adjuvant for many years.

Monday, June 3, 2024 Researchers Identify How Delta Inulin Vaccine Adjuvant Works Hand injects vaccine through a syringe into a person's shoulder muscle. Credit: NIAID After decades of mystery, scientists have uncovered how the NIAID-supported delta inulin vaccine adjuvant works, lowering the hurdle to regulatory approval for vaccine candidates that contain it. Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance vaccine effectiveness. NIAID has funded the discovery and development of the delta inulin adjuvant for many years, currently through a tuberculosis vaccine adjuvant research program. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107